Filing Details

Accession Number:
0001140361-10-030575
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-28 13:00:00
Reporting Period:
2010-07-26
Filing Date:
2010-07-28
Accepted Time:
2010-07-28 13:06:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401782 Mark Wood 105 Digital Drive
C/O Biomarin Pharmaceutical Inc.
Novato CA 94949
Vp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-07-26 1,875 $14.39 16,118 No 4 M Direct
Common Stock Acquisiton 2010-07-26 625 $14.00 16,743 No 4 M Direct
Common Stock Disposition 2010-07-26 1,875 $21.00 14,868 No 4 S Direct
Common Stock Disposition 2010-07-26 625 $21.00 14,243 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2010-07-26 1,875 $0.00 1,875 $14.39
Common Stock Stock Option (right to buy) Acquisiton 2010-07-26 625 $0.00 625 $14.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
162,543 2009-11-12 2019-05-11 No 4 M Direct
163,168 2006-12-21 2016-06-20 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 105-1 Trading plan executed on September 2, 2009.
  2. Original option grant vests 6/48ths on November 12, 2009 and 1/48th on the 12th of each month thereafter.
  3. Original option grant vests 6/48ths on December 21, 2006 and 1/48th on the 21st of each month thereafter.